References
- Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin. Rev. Allergy Immunol. 22(3), 320–323 (2013).
- Mok CC. Vitamin D and systemic lupus erythematosus: an update. Expert. Rev. Clin. Immunol. 9(5), 453–463 (2013).
- Hajas A, Sandor J, Csathy L et al. Vitamin D insufficiency in a large MCTD population. Autoimmun. Rev. 10(6), 317–324 (2011).
- Orbach H, Zandman-Goddard G, Amital H et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann. NY Acad. Sci. 1109, 385–400 (2007).
- Peelen E, Knippenberg S, Muris AH et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun. Rev. 10(12), 733–743 (2011).
- Zold E, Szodoray P, Nakken B et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun. Rev. 10(3), 155–162 (2011).
- Sternberg Z. Autonomic dysfunction: a unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein–Barr virus. Autoimmun. Rev. 12(2), 250–259 (2012).
- Sadovnick AD. Genetic background of multiple sclerosis. Autoimmun. Rev. 11(3), 163–166 (2012).
- Arnson Y, Amital H, Agmon-Levin N et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun. Rev. 10(8), 490–494 (2011).
- Humbert P, Dupond JL, Agache P et al. Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trial. Acta Derm. Venereol. 73(6), 449–451 (1993).
- Capitanio S, Sambuceti G, Giusti M et al. 1,25-dihydroxy vitamin D and coronary microvascular function. Eur. J. Nucl. Med. Mol. Imaging 40(2), 280–289 (2013).
- Munisamy S, Kamaliah MD, Suhaidarwani AH, Zahiruddin WM, Rasool AH. Impaired microvascular endothelial function in vitamin D-deficient diabetic nephropathy patients. Eur. J. Nucl. Med. Mol. Imaging 40(2), 280–289 (2013).
- Wang TJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503–511 (2013).
- Agmon-Levin N, Blank M, Zandman-Goddard G et al. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann. Rheum. Dis. 70(1), 145–150 (2011).
- Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun. Rev. 11(2), 84–87 (2011).
- Moroni L, Bianchi I, Lleo A. Geoepidemiology, gender and autoimmune disease. Autoimmun. Rev. 11(6–7), A386–A392 (2012).
- Hsieh CC, Lin BF. Dietary factors regulate cytokines in murine models of systemic lupus erythematosus. Autoimmun. Rev. 11(1), 22–27 (2011).
- Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun. Rev. 12(2), 127–136 (2012).
- Shepshelovich D, Shoenfeld Y. Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity. Lupus 15(3), 183–190 (2006).
- Souberbielle JC, Body JJ, Lappe JM et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun. Rev. 9(11), 709–715 (2010).
- Agmon-Levin N, Shoenfeld Y. Prediction and prevention of autoimmune skin disorders. Arch. Dermatol. Res. 301(1), 57–64 (2009).